EKSO logo

Ekso Bionics Holdings (EKSO) Cash From Investing

Annual CFI

-$157.00 K
+$5.02 M+96.97%

December 31, 2023

Summary

Performance

1-Year Change

+96.97%

3-Year Change

-100%

5-Year Change

-19.85%

15-Year Change

+65.57%

EKSO Cash From Investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

54.01%
EKSO annual cash flow from investing activities is higher than 54.01% of companies in Healthcare sector

High & Low

All-time High

$0.00
EKSO annual cash flow from investing activities is currently <-9900.00% below its historical high of $0.00

3-Year Low

-$5.17 M

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
EKSO previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

Mar 4, 2025
EKSO next annual earnings announcement is scheduled for Mar 4, 2025

OtherEKSOcash flowmetrics:

Annual CFF

$348.00 K
EKSO annual cash flow from financing activities is $348.00 thousand

Annual CFO

-$12.05 M
EKSO annual cash flow from operations is -$12.05 million

Annual FCF

-$12.21 M
EKSO annual free cash flow is -$12.21 million

Annual CAPEX

$157.00 K
EKSO annual capital expenditures is $157.00 thousand

Quarterly CFI

-$8000.00
-$8000.00-100.00%

September 30, 2024

Summary

Performance

3-Month Change

-100%

1-Year Change

-100%

3-Year Change

+86.67%

5-Year Change

-100%

EKSO Quarterly CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

52.7%
EKSO quarterly cash flow from investing activities is higher than 52.7% of companies in Healthcare sector

High & Low

All-time High

$1000.00
EKSO quarterly cash flow from investing activities is currently -900.00% below its historical high of $1000.00

3-Year Low

-$5.03 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
EKSO previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Mar 4, 2025
EKSO next earnings announcement is scheduled for Mar 4, 2025

OtherEKSOcash flowmetrics:

Quarterly CFF

$4.69 M
EKSO quarterly cash flow from financing activities is $4.69 million

Quarterly CFO

-$2.28 M
EKSO quarterly cash flow from operations is -$2.28 million

Quarterly FCF

-$2.29 M
EKSO quarterly free cash flow is -$2.29 million

Quarterly CAPEX

$8000.00
EKSO quarterly capital expenditures is $8000.00

TTM CFI

-$59.00 K
+$9000.00+13.24%

September 30, 2024

Summary

Performance

3-Month Change

+13.24%

1-Year Change

+13.24%

3-Year Change

+1.67%

5-Year Change

+1.67%

EKSO TTM CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

57.46%
EKSO TTM cash flow from investing activities is higher than 57.46% of companies in Healthcare sector

High & Low

All-time High

$0.00
EKSO TTM cash flow from investing activities is currently <-9900.00% below its historical high of $0.00

3-Year Low

-$5.27 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
EKSO previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Mar 4, 2025
EKSO next earnings announcement is scheduled for Mar 4, 2025

OtherEKSOcash flowmetrics:

TTM CFF

$8.43 M
EKSO TTM cash flow from financing activities is $8.43 million

TTM CFO

-$10.00 M
EKSO TTM cash flow from operations is -$10.00 million

TTM FCF

-$10.06 M
EKSO TTM free cash flow is -$10.06 million

TTM CAPEX

$59.00 K
EKSO TTM capital expenditures is $59.00 thousand

Cash From Investing Formula

CFI = Cash Inflows from Investments − Cash Outflows for Investments

EKSO Cash From Investing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+97.0%-100.0%+13.2%
3 y3 years-100.0%+86.7%+1.7%
5 y5 years-19.9%-100.0%+1.7%

EKSO Cash From Investing Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-166.1%+97.0%-900.0%+99.8%at high+98.9%
5 y5-year<-9999.0%+97.0%-900.0%+99.8%<-9999.0%+98.9%
alltimeall time<-9999.0%+97.0%-900.0%+99.8%<-9999.0%+98.9%

Ekso Bionics Holdings Cash From Investing History

DateAnnualQuarterlyTTM
Sep 2024
-
-$8000.00(<-9900.0%)
-$59.00 K(-13.2%)
Jun 2024
-
$0.00(-100.0%)
-$68.00 K(-44.7%)
Mar 2024
-
-$8000.00(-81.4%)
-$123.00 K(-21.7%)
Dec 2023
-$157.00 K(-97.0%)
-$43.00 K(+152.9%)
-$157.00 K(-97.0%)
Sep 2023
-
-$17.00 K(-69.1%)
-$5.15 M(-2.4%)
Jun 2023
-
-$55.00 K(+31.0%)
-$5.27 M(+1.1%)
Mar 2023
-
-$42.00 K(-99.2%)
-$5.22 M(+0.8%)
Dec 2022
-$5.17 M(+8671.2%)
-$5.03 M(+3470.2%)
-$5.17 M(+3596.4%)
Sep 2022
-
-$141.00 K(<-9900.0%)
-$140.00 K(+137.3%)
Jun 2022
-
$0.00(0.0%)
-$59.00 K(0.0%)
Mar 2022
-
$0.00(-100.0%)
-$59.00 K(0.0%)
Dec 2021
-$59.00 K(<-9900.0%)
$1000.00(-101.7%)
-$59.00 K(-1.7%)
Sep 2021
-
-$60.00 K(<-9900.0%)
-$60.00 K(<-9900.0%)
Dec 2020
$0.00(-100.0%)
$0.00(0.0%)
$0.00(0.0%)
Sep 2020
-
$0.00(0.0%)
$0.00(-100.0%)
Dec 2019
-$60.00 K(-54.2%)
$0.00(0.0%)
-$60.00 K(-57.1%)
Sep 2019
-
$0.00(-100.0%)
-$140.00 K(-12.5%)
Jun 2019
-
-$53.00 K(+657.1%)
-$160.00 K(+49.5%)
Mar 2019
-
-$7000.00(-91.3%)
-$107.00 K(-18.3%)
DateAnnualQuarterlyTTM
Dec 2018
-$131.00 K(-71.3%)
-$80.00 K(+300.0%)
-$131.00 K(-14.9%)
Sep 2018
-
-$20.00 K(<-9900.0%)
-$154.00 K(-35.6%)
Jun 2018
-
$0.00(-100.0%)
-$239.00 K(-31.5%)
Mar 2018
-
-$31.00 K(-69.9%)
-$349.00 K(-23.5%)
Dec 2017
-$456.00 K(-58.4%)
-$103.00 K(-1.9%)
-$456.00 K(-36.8%)
Sep 2017
-
-$105.00 K(-4.5%)
-$721.00 K(-3.5%)
Jun 2017
-
-$110.00 K(-20.3%)
-$747.00 K(-21.3%)
Mar 2017
-
-$138.00 K(-62.5%)
-$949.00 K(-13.4%)
Dec 2016
-$1.10 M(-26.5%)
-$368.00 K(+180.9%)
-$1.10 M(-12.9%)
Sep 2016
-
-$131.00 K(-58.0%)
-$1.26 M(-17.8%)
Jun 2016
-
-$312.00 K(+9.5%)
-$1.53 M(+2.3%)
Mar 2016
-
-$285.00 K(-46.2%)
-$1.50 M(+0.3%)
Dec 2015
-$1.49 M(+0.3%)
-$530.00 K(+31.5%)
-$1.49 M(-8.8%)
Sep 2015
-
-$403.00 K(+45.0%)
-$1.64 M(+10.9%)
Jun 2015
-
-$278.00 K(-1.1%)
-$1.47 M(-9.1%)
Mar 2015
-
-$281.00 K(-58.3%)
-$1.62 M(+9.2%)
Dec 2014
-$1.49 M
-$673.30 K(+177.5%)
-$1.49 M(+82.7%)
Sep 2014
-
-$242.60 K(-43.1%)
-$813.80 K(+42.5%)
Jun 2014
-
-$426.50 K(+194.7%)
-$571.20 K(+294.7%)
Mar 2014
-
-$144.70 K
-$144.70 K

FAQ

  • What is Ekso Bionics Holdings annual cash flow from investing activities?
  • What is the all time high annual CFI for Ekso Bionics Holdings?
  • What is Ekso Bionics Holdings annual CFI year-on-year change?
  • What is Ekso Bionics Holdings quarterly cash flow from investing activities?
  • What is the all time high quarterly CFI for Ekso Bionics Holdings?
  • What is Ekso Bionics Holdings quarterly CFI year-on-year change?
  • What is Ekso Bionics Holdings TTM cash flow from investing activities?
  • What is the all time high TTM CFI for Ekso Bionics Holdings?
  • What is Ekso Bionics Holdings TTM CFI year-on-year change?

What is Ekso Bionics Holdings annual cash flow from investing activities?

The current annual CFI of EKSO is -$157.00 K

What is the all time high annual CFI for Ekso Bionics Holdings?

Ekso Bionics Holdings all-time high annual cash flow from investing activities is $0.00

What is Ekso Bionics Holdings annual CFI year-on-year change?

Over the past year, EKSO annual cash flow from investing activities has changed by +$5.02 M (+96.97%)

What is Ekso Bionics Holdings quarterly cash flow from investing activities?

The current quarterly CFI of EKSO is -$8000.00

What is the all time high quarterly CFI for Ekso Bionics Holdings?

Ekso Bionics Holdings all-time high quarterly cash flow from investing activities is $1000.00

What is Ekso Bionics Holdings quarterly CFI year-on-year change?

Over the past year, EKSO quarterly cash flow from investing activities has changed by -$8000.00 (-100.00%)

What is Ekso Bionics Holdings TTM cash flow from investing activities?

The current TTM CFI of EKSO is -$59.00 K

What is the all time high TTM CFI for Ekso Bionics Holdings?

Ekso Bionics Holdings all-time high TTM cash flow from investing activities is $0.00

What is Ekso Bionics Holdings TTM CFI year-on-year change?

Over the past year, EKSO TTM cash flow from investing activities has changed by +$9000.00 (+13.24%)